Cargando…
B-Cell Responses to Sars-Cov-2 mRNA Vaccines
Most vaccines against viral pathogens protect through the acquisition of immunological memory from long-lived plasma cells that produce antibodies and memory B cells that can rapidly respond upon an encounter with the pathogen or its variants. The COVID-19 pandemic and rapid deployment of effective...
Autores principales: | Kardava, Lela, Buckner, Clarisa M., Moir, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pathogens and Immunity
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836209/ https://www.ncbi.nlm.nih.gov/pubmed/36655200 http://dx.doi.org/10.20411/pai.v7i2.550 |
Ejemplares similares
-
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
por: Lopes de Assis, Felipe, et al.
Publicado: (2023) -
Pre-vaccination and early B cell signatures predict antibody response to SARS-CoV-2 mRNA vaccine
por: Kardava, Lela, et al.
Publicado: (2021) -
2368. SARS-CoV-2 mRNA vaccination induces B cell immunity in the tonsils and adenoids of children
por: Xu, Qin, et al.
Publicado: (2023) -
Early human B cell signatures of the primary antibody response to mRNA vaccination
por: Kardava, Lela, et al.
Publicado: (2022) -
Recent SARS-CoV-2 infection abrogates antibody and B-cell responses to booster vaccination
por: Buckner, Clarisa M., et al.
Publicado: (2022)